Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

“Differently from the US, in Europe most of the reimbursement is managed at the national level, so not at the European Union ...

Last year, surgeons in the US carried out the first transplant of a genetically modified pig kidney into a male subject, who ...

New US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he intends to save $1.8 billion per year, ...

Brian Hilberdink says he wasn’t looking for a new job when he got the call from Boehringer Ingelheim to join up as their new ...

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...

The company ended 2024 with just under $127 million in cash reserves, and nothing in its pipeline beyond the Alzheimer's ...

Eli Lilly's direct-to-consumer platform LillyDirect has been expanded to include in-person and telehealth services for people ...

Alcon said that its majority stake means that Aurion will have "broader R&D, regulatory, medical ophthalmic, and commercial ...

Life Sciences East for its 9th year in Boston, MA to network with 200+ senior HR leaders from Moderna, Takeda, Merck, ...